le Sénégal continue d’être confronté à une crise alimentaire et nutritionnelle qui touche particulièrement le nord et l’est du pays. Selon les estimations faites en novembre 20151, plus de 2,4 millions de personnes sont en insécurité alimentaire (soit 17% de la population), dont 220 461 ...seront en crise pendant la période de soudure 20162. le nombre d’enfants en situation de malnutrition aiguë pourrait être de plus de 407 500 en 2016, parmi lesquels plus de 86 000 en sévère3. les chocs climatiques tels que la sécheresse et le retard de démarrage de la saison pluvieuse ont affecté le nord du pays alors que dans d’autres zones les inondations ont affecté plus de 60 000 personnes4. l’épidémie de la maladie à virus Ebola (MVE) qui a sévi aux portes du pays a montré qu’un renforcement du système de surveillance épidémiologique ainsi que le renforcement des structures de santé sont requis.
more
Today’s children, and their children, are the ones who will live with the consequences of climate change.
West Africa is experiencing the largest, most severe, most complex outbreak of Ebola virus disease in history. On 11 August 2014, WHO convened a consultation where the participants concluded that in the particular context of the current Ebola outbreak in West Africa, it is ethically acceptable to of...fer unproven interventions that have shown promising results in the laboratory and in animal models but have not yet been evaluat-
ed for safety and efficacy in humans as potential treatment or prevention
more
Ebola Virus Disease Outbreak Response Plan in West Africa July to December 2014. Annex 1
Handout presentations in PDF for illustrating lectures
Accessed May 2014
The document summarizes the infrastructure and activities for Ebola virus disease (EVD) preparedness that are already in place in the Gambia and identifies opportunities for improvement to strengthen the nation’s readiness in the event of an EVD incident.
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment of people infecte...d with the Ebola virus:
BCX4430 (Biocryst);
Brincidofovir (Chimerix);
Favipiravir (Fujifilm Corporation/Toyama);
TKM-100802 (Tekmira);
AVI-7537 (Sarepta);
ZMapp (Leafbio Inc.);
Anti-Ebola F(ab’)2 (Fab’entech).
The amount of information available for the seven treatments is highly variable. For some compounds there is no data from use in human subjects available. A small number of treatments have been administered to patients in the current Ebola outbreak as compassionate use. Finally, there are also medicines included in this review that have already been studied in humans, albeit for the treatment of other viral diseases.
more
BMC Medicine 2014, 12:196
http://www.biomedcentral.com/1741-7015/12/196
Desk Review and Recommendations for Private Sector Engagement
Glob Health Sci Pract February 1, 2014 vol. 2 no. 1 p. 103-116